Business Segments · Total segment depreciation and amortization
Prescription Technology Solutions — Total segment depreciation and amortization
McKesson Prescription Technology Solutions — Total segment depreciation and amortization increased by 5.0% to $21.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.5%, from $22.00M to $21.00M. Over 4 years (FY 2021 to FY 2025), Prescription Technology Solutions — Total segment depreciation and amortization shows relatively stable performance with a -0.3% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2025
Rolls up toD&A
How to read this metric
An increase often reflects high levels of capital investment or recent acquisitions of technology assets.
Detailed definition
This metric represents the total non-cash charges for the depreciation of tangible assets and the amortization of intang...
Peer comparison
Standard depreciation and amortization metric reported for all business segments in financial statements.
Metric ID:
mck_segment_prescription_technology_solutions_total_segment_depreciation_and_amortizationHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.75M | $21.75M | $21.75M | $20.50M | $20.50M | $20.50M | $20.50M | $19.25M | $19.25M | $19.25M | $19.25M | $19.00M | $21.00M | $22.00M | $22.00M | $24.00M | $21.00M | $20.00M | $21.00M |
| QoQ Change | — | +0.0% | +0.0% | -5.7% | +0.0% | +0.0% | +0.0% | -6.1% | +0.0% | +0.0% | +0.0% | -1.3% | +10.5% | +4.8% | +0.0% | +9.1% | -12.5% | -4.8% | +5.0% |
| YoY Change | — | — | — | — | -5.7% | -5.7% | -5.7% | -6.1% | -6.1% | -6.1% | -6.1% | -1.3% | +9.1% | +14.3% | +14.3% | +26.3% | +0.0% | -9.1% | -4.5% |
Range$19.00M – $24.00M
CAGR-0.8%
Avg YoY Growth+0.5%
Median YoY Growth-5.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — total segment depreciation and amortization?
- McKesson (MCK) reported prescription technology solutions — total segment depreciation and amortization of $21.00M in Q4 2025.
- How has McKesson's prescription technology solutions — total segment depreciation and amortization changed year-over-year?
- McKesson's prescription technology solutions — total segment depreciation and amortization decreased by 4.5% year-over-year, from $22.00M to $21.00M.
- What is the long-term trend for McKesson's prescription technology solutions — total segment depreciation and amortization?
- Over 4 years (2021 to 2025), McKesson's prescription technology solutions — total segment depreciation and amortization has grown at a -0.3% compound annual growth rate (CAGR), from $87.00M to $86.00M.
- What does prescription technology solutions — total segment depreciation and amortization mean?
- The total non-cash expense for the wear and tear of assets and the write-off of intangible assets in this segment.